HUMALOG

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug HUMALOG contains one active pharmaceutical ingredient (API):

1
UNII GFX7QIS1II - INSULIN LISPRO
 

The primary activity of insulin lispro is the regulation of glucose metabolism.

 
Read more about Insulin lispro

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 HUMALOG 100 units/ml Solution for injection in vial / Cartridge / KwikPen - Junior KwikPen MPI, EU: SmPC European Medicines Agency (EU)
 HUMALOG Mix25 100 units/ml Suspension for injection in vial / cartridge / KwikPen pre-filled pen MPI, EU: SmPC European Medicines Agency (EU)
 HUMALOG 200 units/ml Solution for injection KwikPen pre-filled pen MPI, EU: SmPC European Medicines Agency (EU)
 HUMALOG Mix50 100 units/ml Suspension for injection in cartridge / KwikPen pre-filled pen MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A10AB04 Insulin lispro A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB04
A10AD04 Insulin lispro A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting
Discover more medicines within A10AD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 11645X, 12234X, 12237C, 12261H, 8084L, 8212F, 8390N, 8874C
BR Câmara de Regulação do Mercado de Medicamentos 507601401157310, 507601402153319, 507601405152216, 507604102150416, 507604201159314, 507604301153210, 507604801156219, 507604901150417, 507605001153418, 507605002151419, 507605101158411
CA Health Products and Food Branch 02229704, 02229705, 02240294, 02240297, 02403412, 02403420, 02403439, 02439611, 02470152
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 29665-02-11, 29678-02-11
EE Ravimiamet 1012420, 1012431, 1040409, 1043008, 1043019, 1111284, 1213568, 1213580, 1213591, 1213995, 1214020, 1214053, 1216752, 1216763, 1216785, 1216796, 1216808, 1216853, 1216875, 1226999, 1227002, 1364510, 1364521, 1364532, 1364543, 1364554, 1364565, 1364576, 1364587, 1713248, 1713259, 1713260, 1713271, 1754681, 1754692
ES Centro de información online de medicamentos de la AEMPS 196007041, 196007044, 96007002, 96007031, 96007033, 96007035
FI Lääkealan turvallisuus- ja kehittämiskeskus 031088, 156495, 156506, 156517, 433086, 484224, 556964
FR Base de données publique des médicaments 61650831, 61872223, 64052173, 65132156, 65228400, 66081056, 66537912, 67759549, 69304169
GB Medicines & Healthcare Products Regulatory Agency 103450, 138781, 138848, 138850, 142479, 142481, 142485, 165304, 180488, 187454, 187456, 196132, 196134, 196140, 289269, 32758, 32804, 32848, 352170, 374393, 374395, 375506, 375511, 376664, 379719, 379721, 379723, 392308
HK Department of Health Drug Office 42886, 42887, 60379, 60380, 60381
IE Health Products Regulatory Authority 41045, 41046, 69001, 69050, 69057, 69091, 69105, 69132, 69148, 69184
IL מִשְׂרַד הַבְּרִיאוּת 3323, 3436, 6628, 6629, 6630, 7998, 9164
JP 医薬品医療機器総合機構 2492414A1026, 2492414A2030, 2492414A3029, 2492414A4025, 2492414G5024, 2492414G6020, 2492414G7027, 2492414G9020
LT Valstybinė vaistų kontrolės tarnyba 1004386, 1004509, 1004510, 1004662, 1005038, 1005039, 1005040, 1005172, 1028868, 1028870, 1028876, 1032128, 1032129, 1032130, 1032131, 1058362, 1075234, 1075235, 1075236, 1075237, 1084273, 1084274, 1084275, 1088015, 1088016, 1088017, 1091111, 1091112, 1091113
NG Registered Drug Product Database A6-0617, A6-0618
Switch country to Nigeria in order to find specific presentations of HUMALOG
NL Z-Index G-Standaard 14002248, 14255340, 15027759
NL Z-Index G-Standaard, PRK 121363, 121371, 121398, 121916, 65722, 65838, 65854, 65862
NZ Medicines and Medical Devices Safety Authority 7450, 7451, 9008, 9009, 9010, 9011
PL Rejestru Produktów Leczniczych 100029325, 100029348, 100090709, 100090744, 100197420, 100197436, 100197459, 100208677, 100310453, 100417866, 100461206
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W03665001, W03665002, W12817001, W12817002, W12817003, W52601001, W52601002, W52602001, W52602002, W52605001, W53873001, W53873002, W53874001, W53874002, W53875001, W53875002, W62269001, W64009002
SG Health Sciences Authority 09533P, 11171P, 11227P, 13719P, 14025P
TR İlaç ve Tıbbi Cihaz Kurumu 8699673774152, 8699673774169, 8699673954196, 8699673954202, 8699673954226, 8699673954271, 8699673954288, 8699673954301, 8699673954516, 8699673954523, 8699673954530, 8699673954547
US FDA, National Drug Code 0002-7510, 0002-7511, 0002-7512, 0002-7516, 0002-7712, 0002-7714, 0002-8213, 0002-8797, 0002-8798, 0002-8799, 50090-1663, 50090-4488, 70518-2264
ZA Health Products Regulatory Authority 33/21.1/0073, 33/21.1/0074, 50/21.1/0680

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.